CLDX Equity Ratio

Celldex Therapeutics Inc · Equity Ratio

CLDX logo

CLDX Equity Ratio

Current (TTM)91.34%
CLDX Equity Ratio (71.23% → 91.34%)
High-resolution chart · PNG

CLDX equity ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Celldex Therapeutics Inc Equity Ratio — Annual fiscal periods
Period endingEquity Ratio
90.4254%
94.2783%
92.1706%
92.4785%
94.3376%
88.7715%
76.4856%
79.6231%
74.8894%
69.2384%
85.9356%
85.342%
92.1347%
76.289%
70.1288%
68.4491%
52.5541%
25.982%
-50.5828%
3.515%
57.306%
83.8532%
89.1858%
88.9627%
84.6388%
84.8481%
87.5786%
82.8194%
64.2857%
90.6977%
86.4865%
85.0242%
87.9154%
87.9464%
78.7879%
83.9744%
63.6364%
71.5385%
71.2329%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.